Enhanced factor VIII gene therapy for hemophilia a dogs with a novel Furin-evading factor VIII variant

被引：0
|
作者：
Siner, J., I [1 ]
Samelson-Jones, B. [1 ]
Crudele, J. M. [2 ]
Zhou, S. [3 ]
Merricks, E. [4 ]
Nichols, T. [4 ]
Camire, R. M. [1 ]
Arruda, V. R. [1 ]
机构：
[1] Childrens Hosp Philadelphia, Div Hematol, Pediat, Philadelphia, PA 19104 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[4] Univ N Carolina, Pathol & Lab Med, Chapel Hill, NC USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AS120
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [1] A Novel Factor VIII Variant with Enhanced Secretion for Gene Therapy of Hemophilia A
    Cao, Wenjing
    Dong, Biao
    Firrman, Jenni A.
    Moore, Andrea R.
    Wang, Qizhao
    Roberts, Sean A.
    Xiao, Weidong
    MOLECULAR THERAPY, 2014, 22 : S176 - S176
  • [2] An Enhanced Hemostatic Factor VIII Variant for Hemophilia A Gene Therapy
    Sternberg, Anna R.
    Davidson, Robert J.
    Wilhelm, Amelia R.
    George, Lindsey A.
    MOLECULAR THERAPY, 2022, 30 (04) : 328 - 329
  • [3] Enhanced Factor VIII Heavy Chain for Gene Therapy of Hemophilia A
    Chen, Lingxia
    Lu, Hui
    Wang, Jinhui
    Sarkar, Rita
    Yang, Xiao
    Wang, Hongli
    High, Katherine A.
    Xiao, Weidong
    MOLECULAR THERAPY, 2009, 17 (03) : 417 - 424
  • [4] Novel factor VIII variants with a modified furin cleavage site improve the efficacy of gene therapy for hemophilia A
    Nguyen, G. N.
    George, L. A.
    Siner, J. I.
    Davidson, R. J.
    Zander, C. B.
    Zheng, X. L.
    Arruda, V. R.
    Camire, R. M.
    Sabatino, D. E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (01) : 110 - 121
  • [5] Localization of non-factor VIII sequence involved in the factor VIII gene inversion in hemophilia A dogs.
    Lozier, Jay Nelson
    Weeks, Brian
    Tayebi, Nahid
    BLOOD, 2007, 110 (11) : 347A - 348A
  • [6] Variant of intron 22 inversions in the factor VIII gene in severe hemophilia A
    Yamazaki, E
    Mohri, H
    Inaba, H
    Harano, H
    Kanamori, H
    Okubo, T
    BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 (07) : 445 - 449
  • [7] Factor VIII Immunogenicity Is a Barrier to AAV Gene Therapy for Hemophilia A
    Lytle, Allison M.
    Brown, Harrison C.
    Spencer, H. Trent
    Doering, Christopher B.
    MOLECULAR THERAPY, 2015, 23 : S95 - S96
  • [8] FACTOR-VIII GENE AND HEMOPHILIA-A
    WHITE, GC
    SHOEMAKER, CB
    BLOOD, 1989, 73 (01) : 1 - 12
  • [9] FACTOR-VIII - VARIANT OF FACTOR-VIII
    FINEMAN, RM
    JOHNSON, AM
    MCMILLAN, CW
    PEDIATRIC RESEARCH, 1975, 9 (04) : 321 - 321
  • [10] Improved Factor VIII Expression with the Introduction of a PACE-Furin Variant into Codon-Optimized Human Factor VIII
    Elkouby, Liron
    Davidson, Robert J.
    Margaritis, Paris
    High, Katherine A.
    Sabatino, Denise E.
    BLOOD, 2014, 124 (21)
12345